- Home
- Companies
- usa north carolina
- cancer treatment
Show results for
Refine by
Cancer Treatment Suppliers In Usa North Carolina
6 companies found
based inMorrisville, NORTH CAROLINA (USA)
NantHealth empowers the creation of integrated healthcare delivery networks. In developing technology that supports systems and data, we enable efficiency, personalized treatment, and collaboration across health care. NantHealth is recognized by ...
Payers, seeking a clearer view into treatment validity, turn to Eviti Connect. Focused on high-quality, high-value care, the platform offers insight payers need to make reimbursement decisions. For payers, Eviti Connect ...
based inRaleigh, NORTH CAROLINA (USA)
Kaio's strategy is to develop and in-license technologies and therapies that enable the body’s own immune system to work more efficiently. The goal is to improve clinical outcomes for patients, increase the number and efficacy of therapeutic options ...
based inMorrisville, NORTH CAROLINA (USA)
Our mission is to provide comprehensive personalized molecular solutions to inform cancer care. NantOmics, a member of the NantWorks ecosystem of companies, is a leader in molecular diagnostic testing and the first company to employ an integrated ...
Evidence-Based Treatment Intelligence for Improved Outcomes in Oncology. Cancer research is ever-evolving. Often, physicians struggle to manage overwhelming amounts of information around the risks, benefits, and ...
based inFort Myers, FLORIDA (USA)
NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with ...
This allows RaDaR™ to detect traces of molecular residual disease (MRD) in a patient following surgery or other treatment for cancer, enabling early detection of relapse and accurate monitoring. ...
based inDurham, NORTH CAROLINA (USA)
Cancer is the second leading cause of death in the U.S. and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the most effective ...
Xilis is developing a panel of disease specific assays systematically testing the most important standard-of-care drugs within equipoise or difficult-decision settings to help clinicians and their patients make the most appropriate ...
based inDurham, NORTH CAROLINA (USA)
Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them. Symberix’s scientific ...